News Corporate Actions Nectar Lifesciences Promoters' Shareholding Increases to 51.84% Post Share BuybackNectar Lifesciences Promoters' Shareholding Increases to 51.84% Post Share Buyback
Nectar Lifesciences Limited's promoter and promoter group shareholding increased from 44.91% to 51.84% following completion of a share buyback program that concluded on January 06, 2026. The promoters maintained their absolute shareholding of 10,07,06,448 shares while their percentage increased due to the extinguishment of 30,00,000 shares on January 20, 2026. The transaction was disclosed under SEBI Takeover Regulations and qualified for exemption from open offer requirements under Regulation 10(4)(c).
*this image is generated using AI for illustrative purposes only.
Nectar Lifesciences Limited has reported a significant increase in promoter shareholding following the completion of its share buyback program. The company filed a disclosure under SEBI Takeover Regulations on January 27, 2026, detailing the changes in shareholding structure.
Promoter Shareholding Changes
The promoter and promoter group's collective shareholding increased substantially due to the share buyback completion. While the absolute number of shares held by promoters remained unchanged, their percentage stake in the company rose significantly.
| Promoter Details: | Pre-Buyback Shares | Pre-Buyback % | Post-Buyback Shares | Post-Buyback % | Increase (%) |
|---|---|---|---|---|---|
| Sanjiv Goyal: | 4,78,45,600 | 21.33 | 4,78,45,600 | 24.63 | 3.29 |
| Sanjiv (HUF): | 4,36,22,400 | 19.45 | 4,36,22,400 | 22.46 | 3.00 |
| Raman Goyal: | 92,38,448 | 4.12 | 92,38,448 | 4.76 | 0.64 |
| Total Promoters: | 10,07,06,448 | 44.91 | 10,07,06,448 | 51.84 | 6.93 |
Share Buyback Details
The change in shareholding percentage resulted from the company's share buyback program rather than any fresh acquisition by promoters. The buyback program commenced on December 31, 2025, and concluded on January 06, 2026. The company subsequently extinguished 30,00,000 shares on January 20, 2026.
| Buyback Parameters: | Details |
|---|---|
| Program Duration: | December 31, 2025 to January 06, 2026 |
| Shares Extinguished: | 30,00,000 |
| Extinguishment Date: | January 20, 2026 |
| Impact on Public Holding: | Decreased from 55.09% to 48.16% |
Regulatory Compliance
The disclosure was made under Regulation 10(6) of SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. The transaction qualified for exemption under Regulation 10(4)(c), which meant no open offer was required despite the substantial increase in promoter shareholding.
Key regulatory aspects include:
- No prior intimation required under Regulation 10(5)
- Exemption from open offer provisions
- Compliance with post-transaction disclosure requirements
- Filing with both BSE Limited and National Stock Exchange of India Limited
Impact on Share Capital Structure
The buyback resulted in a reduction of the company's total share capital from 2,24,26,097 shares to 1,94,26,097 shares. The public shareholding decreased correspondingly from 1,23,55,452 shares to 93,55,452 shares, representing a decline from 55.09% to 48.16% of the total share capital.
The promoters now hold majority control of Nectar Lifesciences Limited with their combined 51.84% stake, marking a significant shift in the company's ownership structure following the successful completion of the share buyback program.
Historical Stock Returns for Nectar Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.58% | -7.86% | -37.30% | -20.74% | -64.51% | -31.62% |
19
